Esophagectomy is one of the most demanding operations in surgery — and the one where a minimally-invasive, robotic approach makes the biggest difference. Robot-assisted esophagectomy (RAMIE) roughly halves the serious lung and heart complications of open surgery, with the same cancer clearance. Dr. Vinod T. Gore performs robotic and minimally-invasive esophagectomy for both squamous and adenocarcinoma.
The esophagus (food pipe) is the muscular tube that carries food from the throat to the stomach. Cancer can arise anywhere along it, and the first sign is usually difficulty swallowing that slowly worsens.
There are two main types, and they behave differently. Squamous cell carcinoma (SCC) usually affects the upper and middle esophagus and is linked to smoking, alcohol and very hot drinks — it is the more common type in India and Asia. Adenocarcinoma affects the lower esophagus and the junction with the stomach, and is linked to acid reflux, Barrett’s esophagus and obesity.
The type and the location decide the treatment — including whether radiotherapy plays a leading role and where the surgical join is made. Most patients with localised disease today are treated with a combination of chemotherapy, radiotherapy and surgery, sequenced for their tumour.
The cell type and where the cancer sits shape the whole treatment plan — especially how big a role radiotherapy plays and where the surgeon rebuilds the swallowing pipe.
Squamous and adenocarcinoma have largely different causes — which is why prevention advice differs. Many of these factors are modifiable.
Prevention & early detection: not smoking, limiting alcohol, avoiding very hot drinks, controlling reflux and maintaining a healthy weight all lower the risk. People with Barrett’s esophagus benefit from surveillance endoscopy to catch changes early.
The classic warning sign is swallowing that becomes harder over weeks — first with solid food, then softer foods. New, progressive difficulty swallowing always needs an urgent endoscopy.
Staging uses endoscopy with biopsy, endoscopic ultrasound (EUS) for tumour depth, CT and PET-CT for spread, and sometimes a staging laparoscopy for junctional tumours.
| Stage | Classification | Description | 5-yr Survival |
|---|---|---|---|
Stage I | T1, N0, M0 | Confined to the inner layers. Very early tumours may be removed endoscopically; others by surgery. | 70–80% |
Stage II | T2–T3, N0, M0 | Into the muscle or outer wall, no nodes. Usually chemoradiation followed by surgery. | 40–55% |
Stage III | T3–T4a or N+ | Deeper invasion or lymph node spread. Chemoradiation (or peri-op chemo) then esophagectomy. | 25–40% |
Stage IV | Any T, Any N, M1 | Spread to distant organs. Systemic therapy; chemoradiation for symptom control in selected cases. | Variable |
Esophageal cancer is treated in a planned sequence — rarely surgery alone — combining drug therapy, radiotherapy and surgery for the best chance of cure.
An esophagectomy removes the cancerous esophagus along with its lymph nodes, and rebuilds the swallowing pipe — usually by bringing the stomach up. The approach is chosen for the tumour’s type and position; wherever possible, Dr. Gore performs it robotically to reduce its considerable morbidity.
Open esophagectomy means large incisions in the chest and abdomen and spreading the ribs — which is why lung complications are so common. RAMIE performs the same operation through small ports, with a magnified 3D view and wristed instruments that move precisely in the narrow space behind the heart and lungs. In the randomised ROBOT trial, this roughly halved serious lung and heart complications, reduced blood loss and pain, and sped recovery — with the same cancer clearance as open surgery. For an operation as demanding as esophagectomy, that reduction in morbidity is genuinely meaningful.
Removing the right lymph nodes is central to curing esophageal cancer. How many ‘fields’ of nodes are taken depends on the tumour’s position and type.
Esophagectomy carries one of the highest complication rates of any cancer operation — chiefly pneumonia and respiratory problems from opening the chest. This is precisely where a robotic, minimally-invasive approach delivers its greatest benefit, which is why Dr. Gore favours RAMIE for suitable patients.
Modern esophageal cancer care is built on strong randomised evidence — both for adding chemotherapy and radiotherapy around surgery, and for the robotic approach to the operation itself.
References: CROSS — van Hagen P et al., N Engl J Med 2012; Shapiro J et al., Lancet Oncol 2015. ROBOT — van der Sluis PC et al., Ann Surg 2019;269:621–630. FLOT4 — Al-Batran SE et al., Lancet 2019. CheckMate 577 — Kelly RJ et al., N Engl J Med 2021. This information is educational and does not replace a personal consultation.
Because open esophagectomy requires opening the chest and spreading the ribs, lung complications such as pneumonia are common and serious. Robotic surgery (RAMIE) performs the same operation through small ports with a magnified 3D view. The randomised ROBOT trial showed this roughly halved serious lung and heart complications, with less blood loss and faster recovery — and the same cancer clearance.
Usually, yes, for locally-advanced tumours. The CROSS regimen (chemotherapy with radiotherapy before surgery) improves survival for both squamous and adenocarcinoma. For junctional adenocarcinoma, perioperative chemotherapy (FLOT) is an alternative. Upper or neck squamous cancers may be treated with chemoradiation alone.
Squamous cell carcinoma usually affects the upper/middle esophagus and is linked to smoking, alcohol and hot drinks; it is very sensitive to radiotherapy. Adenocarcinoma affects the lower esophagus and the junction with the stomach and is linked to reflux, Barrett’s and obesity. The type changes the treatment plan and the type of operation.
Sometimes — particularly squamous cell cancers of the upper esophagus or neck, which can be cured by definitive chemoradiation alone. The decision is individual and made at the tumour board.
Ivor Lewis uses an abdominal and a chest approach, with the join made in the chest — suited to lower and junctional tumours. McKeown adds a neck incision, with the join made in the neck — suited to middle and upper tumours and allowing three-field lymph node removal.
Two-field removes lymph nodes in the abdomen and chest; three-field also removes neck (cervical) nodes. Three-field is considered mainly for upper and middle squamous cancers, where neck nodes are more often involved.
Recovery is supported with early mobilisation and a staged return to eating, often starting with small, frequent meals. With robotic surgery, pain and lung complications are reduced, which helps a smoother recovery. The team and a dietitian support you throughout.
Bring your endoscopy and biopsy report, CT and PET-CT. Dr. Gore reviews everything personally, coordinates your multidisciplinary plan, and explains the robotic surgical options for your tumour.